Influence of the sFlt-1/PlGF ratio on clinical decision-making in women with suspected preeclampsia

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: In: PLoS one, volume 11, issue 5, e0156013 (2016), doi:10.1371/journal.pone.0156013

Keyword: Schwangerschaftsstörung

Event: Veröffentlichung

(where): Frankfurt am Main

(who): Universitätsbibliothek Johann Christian Senckenberg

(when): 2016

Creator: Klein, Evelyn
Schlembach, Dietmar
Ramoni, Angela
Langer, Elena
Bahlmann, Franz
Grill, Sabine
Schaffenrath, Helene
Does, Reinhard van der
Messinger, Diethelm
Verhagen-Kamerbeek, Wilma D. J.
Reim, Manfred
Hund, Martin
Stepan, Holger

URN: urn:nbn:de:hebis:30:3-457790

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:54 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Klein, Evelyn
Schlembach, Dietmar
Ramoni, Angela
Langer, Elena
Bahlmann, Franz
Grill, Sabine
Schaffenrath, Helene
Does, Reinhard van der
Messinger, Diethelm
Verhagen-Kamerbeek, Wilma D. J.
Reim, Manfred
Hund, Martin
Stepan, Holger
Universitätsbibliothek Johann Christian Senckenberg

Time of origin

2016

Other Objects (12)

Evaluation of Angiogenic Factors (PlGF and sFlt-1) in Pre-eclampsia Diagnosis

A dynamic prediction model for preeclampsia using the sFlt-1/PLGF ratio combined with multiple factors

Increased LIGHT leading to sFlt-1 elevation underlies the pathogenic link between hydatidiform mole and preeclampsia

Hochschulschrift

sFlt-1 als diagnostischer Biomarker bei pulmonaler Hypertonie

First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia

Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany

A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia

Applying the concept of uncertainty to the sFlt-1/PlGF cut-offs for diagnosis and prognosis of preeclampsia

$Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix$

Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix

sFlt-1/PIGF ratio positive associated with non-dipper type change in ambulatory blood pressure monitoring(ABPM) for preeclampsia development

Elecsys ® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable?

Clinical value and cost analysis of the sFlt-1/PlGF ratio in addition to the spot urine protein/creatinine ratio in women with suspected pre-eclampsia: PREPARE cohort study

Evaluation of Angiogenic Factors (PlGF and sFlt-1) in Pre-eclampsia Diagnosis

A dynamic prediction model for preeclampsia using the sFlt-1/PLGF ratio combined with multiple factors

Increased LIGHT leading to sFlt-1 elevation underlies the pathogenic link between hydatidiform mole and preeclampsia

Hochschulschrift

sFlt-1 als diagnostischer Biomarker bei pulmonaler Hypertonie

First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia

Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany

A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia

Applying the concept of uncertainty to the sFlt-1/PlGF cut-offs for diagnosis and prognosis of preeclampsia

$Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix$

Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix

sFlt-1/PIGF ratio positive associated with non-dipper type change in ambulatory blood pressure monitoring(ABPM) for preeclampsia development

Elecsys ® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable?

Clinical value and cost analysis of the sFlt-1/PlGF ratio in addition to the spot urine protein/creatinine ratio in women with suspected pre-eclampsia: PREPARE cohort study

Evaluation of Angiogenic Factors (PlGF and sFlt-1) in Pre-eclampsia Diagnosis

A dynamic prediction model for preeclampsia using the sFlt-1/PLGF ratio combined with multiple factors

Increased LIGHT leading to sFlt-1 elevation underlies the pathogenic link between hydatidiform mole and preeclampsia

Hochschulschrift

sFlt-1 als diagnostischer Biomarker bei pulmonaler Hypertonie

First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia

Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany

A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia

Applying the concept of uncertainty to the sFlt-1/PlGF cut-offs for diagnosis and prognosis of preeclampsia

$Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix$

Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix

sFlt-1/PIGF ratio positive associated with non-dipper type change in ambulatory blood pressure monitoring(ABPM) for preeclampsia development

Elecsys ® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable?

Clinical value and cost analysis of the sFlt-1/PlGF ratio in addition to the spot urine protein/creatinine ratio in women with suspected pre-eclampsia: PREPARE cohort study

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Influence of the sFlt-1/PlGF ratio on clinical decision-making in women with suspected preeclampsia

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Evaluation of Angiogenic Factors (PlGF and sFlt-1) in Pre-eclampsia Diagnosis

A dynamic prediction model for preeclampsia using the sFlt-1/PLGF ratio combined with multiple factors

Increased LIGHT leading to sFlt-1 elevation underlies the pathogenic link between hydatidiform mole and preeclampsia

sFlt-1 als diagnostischer Biomarker bei pulmonaler Hypertonie

First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia

Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany

A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia

Applying the concept of uncertainty to the sFlt-1/PlGF cut-offs for diagnosis and prognosis of preeclampsia

Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix

sFlt-1/PIGF ratio positive associated with non-dipper type change in ambulatory blood pressure monitoring(ABPM) for preeclampsia development

Elecsys ® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable?

Clinical value and cost analysis of the sFlt-1/PlGF ratio in addition to the spot urine protein/creatinine ratio in women with suspected pre-eclampsia: PREPARE cohort study

Evaluation of Angiogenic Factors (PlGF and sFlt-1) in Pre-eclampsia Diagnosis

A dynamic prediction model for preeclampsia using the sFlt-1/PLGF ratio combined with multiple factors

Increased LIGHT leading to sFlt-1 elevation underlies the pathogenic link between hydatidiform mole and preeclampsia

sFlt-1 als diagnostischer Biomarker bei pulmonaler Hypertonie

First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia

Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany

A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia

Applying the concept of uncertainty to the sFlt-1/PlGF cut-offs for diagnosis and prognosis of preeclampsia

Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix

sFlt-1/PIGF ratio positive associated with non-dipper type change in ambulatory blood pressure monitoring(ABPM) for preeclampsia development

Elecsys ® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable?

Clinical value and cost analysis of the sFlt-1/PlGF ratio in addition to the spot urine protein/creatinine ratio in women with suspected pre-eclampsia: PREPARE cohort study

Evaluation of Angiogenic Factors (PlGF and sFlt-1) in Pre-eclampsia Diagnosis

A dynamic prediction model for preeclampsia using the sFlt-1/PLGF ratio combined with multiple factors

Increased LIGHT leading to sFlt-1 elevation underlies the pathogenic link between hydatidiform mole and preeclampsia

sFlt-1 als diagnostischer Biomarker bei pulmonaler Hypertonie

First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia

Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany

A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia

Applying the concept of uncertainty to the sFlt-1/PlGF cut-offs for diagnosis and prognosis of preeclampsia

Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix

sFlt-1/PIGF ratio positive associated with non-dipper type change in ambulatory blood pressure monitoring(ABPM) for preeclampsia development

Elecsys ® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable?

Clinical value and cost analysis of the sFlt-1/PlGF ratio in addition to the spot urine protein/creatinine ratio in women with suspected pre-eclampsia: PREPARE cohort study

Related objects

Reset password